Developer docs
API playgroundTry for free, no card

Search company profiles

Premier Partners

Full company profile

uuid0000fan

Namestring
Premier Partners
Legal namestring
Premier Partners, LLC
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Premier Partners, LLC is a Seoul-based, privately-held alternative investment manager founded in 2005 as Korea's first LLC-structured fund management firm. The firm operates three specialized divisions — Private Equity, Venture Capital, and Bio/Healthcare — and manages a cumulative KRW 3.53 trillion (approximately US$2.6 billion) in assets across 12 venture funds and 7 private equity funds. Premier Partners is wholly owned by its 11 operating partners with no external shareholders, and reports an average of 19 years of partner experience with co-founder continuity since 1997.

The firm's underlying investment platform comprises discrete fund vehicles by strategy and vintage, with cross-divisional co-investment capacity supporting Korean growth-stage and venture companies. Operational infrastructure includes a proprietary in-house ERP system for investor reporting, and in 2018 the firm adopted the Korean Stewardship Code, formalizing its ESG and active ownership framework. Recent portfolio activity demonstrates a thematic tilt toward Bio/Healthcare (Mediwhale Series C, Celltrio financing, Kanaph Therapeutics KOSDAQ IPO) alongside diversified venture investments in K-beauty, content, and fintech.

Premier Partners generates revenue through conventional alternative asset manager economics: periodic management fees on committed and invested capital across its 19 funds, plus performance-based carried interest on realizations such as the Kanaph KOSDAQ listing. Limited Partners are primarily Korean institutional investors, anchored by the National Pension Service and supplemented by mutual aid associations and the Korea Investment Corporation, with the firm having secured additional consignment management mandates from these institutions in 2026.

Short descriptiontext

Premier Partners is a Seoul-based, privately-held Korean alternative investment manager operating PE, VC, and Bio/Healthcare funds with KRW 3.53 trillion in cumulative AUM, serving Korean institutional limited partners and growth-stage portfolio companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity funds, venture capital funds, fund management services, growth capital investment, bio healthcare investing
Industry2 codes
1Large-Cap / Mega-Fund Buyout
CodeFSANABAAPrimaryYes
2Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure)
CodeFSAAALAGPrimaryNo
NAICS code3 codes
  • Other Investment Pools and Funds5259
  • Funds, Trusts, and Other Financial Vehicles525
  • Portfolio Management and Investment Advice523940
SIC code2 codes
  • Investment Advice6282
  • Investors, Nec6799
Product category
Private Equity & Venture Capital Fund Management
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management Fees & Carried Interest
TypeManaged Services
Description

Premier Partners generates revenue as a Limited Liability Company (LLC) fund manager operating 12 Venture Funds (VFs) and 7 Private Equity Funds (PEFs) with cumulative AUM of approximately KRW 3.53 trillion. Revenue is derived from management fees on committed/invested capital across pension fund, mutual aid association, financial institution, general corporation, and overseas LPs, supplemented by carried interest (performance fees) on successful exits realized via IPOs and M&A.

premierpartners.co.kr
2Realized Investment Gains (Carry)
TypeSubscription Recurring
Description

Realized Gross IRR on liquidated funds reflects successful exit outcomes through IPOs and M&A across sectors including K-beauty, life sciences/biotech, ICT, and industrials, with GP commitment from operating personnel aligning interests with LPs.

premierpartners.co.kr
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Institutional LP capital commitments to VF and PEF vehicles
ModelOtherBilling cadenceMulti-year contract
Notes

Fees are not publicly disclosed; allocations are made bilaterally with major Korean and overseas institutional investors including the National Pension Service.

premierpartners.co.kr
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Premier Partners is a Korean private equity and venture capital fund management firm operating 12 Venture Funds (VFs) and 7 Private Equity Funds (PEFs) with cumulative AUM of approximately KRW 3.53 trillion. The firm provides growth-stage equity capital, board-level governance, and post-investment value-added support to innovative Korean SMEs and mid-cap companies across three specialized divisions: Private Equity, Venture Capital, and Bio/Healthcare.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • KRW 3.53 trillion cumulative AUM since 2005
+4 more records
Product overview1 text field

Premier Partners is a Korean private equity and venture capital firm operating as an integrated multi-division platform under a single brand. Established in 2005 as Korea's first LLC-structured fund management firm, the offering spans three core investment divisions — Private Equity (PE), Venture Capital (VC), and Bio/Healthcare — which together comprise the firm's product architecture. Each division manages dedicated fund vehicles (12 VFs and 7 PEFs established to date), all backed by a shared investment strategy that combines deep sector expertise, post-investment value-added support, and ESG-integrated decision-making. The Private Equity Fund product targets mid-to-large cap enterprises, the Venture Capital Fund product serves innovative startups, and the Bio/Healthcare Fund product covers life sciences and biotech companies, while the Growth Capital Investment Service cuts across divisions to support portfolio company scaling.

Product and service4 records
1Private Equity (PE) Fund
CategoryInvestment fund — Private Equity
Description

Management-participation type private equity funds (PEFs) targeting mid-to-large cap Korean enterprises with high growth potential and sustainable competitive advantages. Provides management participation, board representation, and post-investment value-added support to portfolio companies.

2Venture Capital (VC) Fund
CategoryInvestment fund — Venture Capital
Description

Venture capital funds targeting innovative Korean startups and early-stage companies with high growth potential across ICT, life sciences, deeptech, content, and Brand & Commerce. Premier Partners has established 12 VFs cumulatively.

3Bio/Healthcare Fund
4Growth Capital Investment Service
CategoryInvestment service — Growth Capital
Description

Provides growth-stage capital and post-investment value-added support for portfolio companies, leveraging partner expertise across sales, procurement, finance, production, and R&D functions to enhance overall business performance.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

H&Q Korea is a Korean mid-market PE/VC firm of similar scale to Premier Partners; both won 2026 mutual aid association consignment management mandates and compete head-to-head for Korean SME and mid-cap investments.

TypeDirect peer
Description

JKL Partners is a mid-sized Korean PE firm that, alongside Premier Partners and H&Q Korea, captured the bulk of 2026 mutual aid and KIC consignment management mandates after NPS withdrew.

TypeBroad incumbent
Description

IMM Private Equity is one of the largest Korean PE firms, named alongside Premier Partners as a competing Korean PE manager for mutual aid and KIC mandates. Premier Partners' portfolio includes Goodai Global, which IMM led at a KRW 4 trillion valuation.

TypeBroad incumbent
Description

MBK Partners is the largest Korean PE firm and a recurring competitor for institutional mandates; Premier Partners is identified alongside MBK in the same mutual aid/KIC mandate ecosystem and competes for capital from the same domestic LP base.

TypeBroad incumbent
Description

Hahn & Company is a major Korean buyout firm competing with Premier Partners for institutional Korean mandates; both firms pursue mid-to-large cap Korean enterprise investments backed by mutual aid, pension, and financial institution LPs.

6Ieum PE (formerly LB Private Equity)
TypeDirect peer
Description

Ieum PE is a mid-sized Korean PE firm that won mutual aid/KIC consignment management mandates in 2026 alongside Premier Partners, with a similar focus on Korean SME and mid-cap transactions.

TypeDirect peer
Description

Korea Investment Partners is the PE/VC arm of Korea Investment Holdings, operating multi-stage funds across Korean growth and buyout opportunities and overlapping Premier Partners' SME/mid-cap investment focus.

TypeDirect peer
Description

Mirae Asset Venture Investment is a Korean VC/PE firm within the Mirae Asset group that invests across early- and growth-stage Korean companies, overlapping Premier Partners' VC and growth-stage mandates.

TypeBroad incumbent
Description

KDB Capital is a state-affiliated Korean investment firm operating venture, growth, and infrastructure funds, competing with Premier Partners for domestic institutional capital and SME/mid-cap deal flow.

TypeRegional player
Description

Korea Growth Finance (Series Investment) is a policy-oriented Korean investment firm that invests in SMEs and venture-stage companies, operating as a comparable Korean domestic capital provider alongside Premier Partners' growth-stage and VC activities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment229 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Premier Partners

Private Equity & Venture Capital Fund Managementpremierpartners.co.kr

Premier Partners is a Seoul-based, privately-held Korean alternative investment manager operating PE, VC, and Bio/Healthcare funds with KRW 3.53 trillion in cumulative AUM, serving Korean institutional limited partners and growth-stage portfolio companies.

What Premier Partners does

Premier Partners, LLC is a Seoul-based, privately-held alternative investment manager founded in 2005 as Korea's first LLC-structured fund management firm. The firm operates three specialized divisions — Private Equity, Venture Capital, and Bio/Healthcare — and manages a cumulative KRW 3.53 trillion (approximately US$2.6 billion) in assets across 12 venture funds and 7 private equity funds. Premier Partners is wholly owned by its 11 operating partners with no external shareholders, and reports an average of 19 years of partner experience with co-founder continuity since 1997.

The firm's underlying investment platform comprises discrete fund vehicles by strategy and vintage, with cross-divisional co-investment capacity supporting Korean growth-stage and venture companies. Operational infrastructure includes a proprietary in-house ERP system for investor reporting, and in 2018 the firm adopted the Korean Stewardship Code, formalizing its ESG and active ownership framework. Recent portfolio activity demonstrates a thematic tilt toward Bio/Healthcare (Mediwhale Series C, Celltrio financing, Kanaph Therapeutics KOSDAQ IPO) alongside diversified venture investments in K-beauty, content, and fintech.

Premier Partners generates revenue through conventional alternative asset manager economics: periodic management fees on committed and invested capital across its 19 funds, plus performance-based carried interest on realizations such as the Kanaph KOSDAQ listing. Limited Partners are primarily Korean institutional investors, anchored by the National Pension Service and supplemented by mutual aid associations and the Korea Investment Corporation, with the firm having secured additional consignment management mandates from these institutions in 2026.

Premier Partners firmographics

Firmographics
Name
Premier Partners
Legal name
Premier Partners, LLC
Website
https://premierpartners.co.kr
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
Premier Partners is a Seoul-based, privately-held Korean alternative investment manager operating PE, VC, and Bio/Healthcare funds with KRW 3.53 trillion in cumulative AUM, serving Korean institutional limited partners and growth-stage portfolio companies.
Ownership category
akta.pro rank

Premier Partners industry classification

Industry
Product category
Private Equity & Venture Capital Fund Management
NAICS
Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282), Investors, Nec (6799)
akta.pro primary industry
Large-Cap / Mega-Fund Buyout (FSANABAA)
akta.pro secondary industry
Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure) (FSAAALAG)

Keywords

  • Private equity funds
  • Venture capital funds
  • Fund management services
  • Growth capital investment
  • Bio healthcare investing

Where Premier Partners is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

Premier Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Fund Management Fees & Carried Interest: Premier Partners generates revenue as a Limited Liability Company (LLC) fund manager operating 12 Venture Funds (VFs) and 7 Private Equity Funds (PEFs) with cumulative AUM of approximately KRW 3.53 trillion. Revenue is derived from management fees on committed/invested capital across pension fund, mutual aid association, financial institution, general corporation, and overseas LPs, supplemented by carried interest (performance fees) on successful exits realized via IPOs and M&A.
  2. Realized Investment Gains (Carry): Realized Gross IRR on liquidated funds reflects successful exit outcomes through IPOs and M&A across sectors including K-beauty, life sciences/biotech, ICT, and industrials, with GP commitment from operating personnel aligning interests with LPs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractInstitutional LP capital commitments to VF and PEF vehicles

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Premier Partners product offering

Product offering

Core offering

Premier Partners is a Korean private equity and venture capital fund management firm operating 12 Venture Funds (VFs) and 7 Private Equity Funds (PEFs) with cumulative AUM of approximately KRW 3.53 trillion. The firm provides growth-stage equity capital, board-level governance, and post-investment value-added support to innovative Korean SMEs and mid-cap companies across three specialized divisions: Private Equity, Venture Capital, and Bio/Healthcare.

Product overview

Premier Partners is a Korean private equity and venture capital firm operating as an integrated multi-division platform under a single brand. Established in 2005 as Korea's first LLC-structured fund management firm, the offering spans three core investment divisions — Private Equity (PE), Venture Capital (VC), and Bio/Healthcare — which together comprise the firm's product architecture. Each division manages dedicated fund vehicles (12 VFs and 7 PEFs established to date), all backed by a shared investment strategy that combines deep sector expertise, post-investment value-added support, and ESG-integrated decision-making. The Private Equity Fund product targets mid-to-large cap enterprises, the Venture Capital Fund product serves innovative startups, and the Bio/Healthcare Fund product covers life sciences and biotech companies, while the Growth Capital Investment Service cuts across divisions to support portfolio company scaling.

Differentiator

Problem solved

Functional benefit

Products and services

  • Private Equity (PE) Fund Management-participation type private equity funds (PEFs) targeting mid-to-large cap Korean enterprises with high growth potential and sustainable competitive advantages. Provides management participation, board representation, and post-investment value-added support to portfolio companies.
  • Venture Capital (VC) Fund Venture capital funds targeting innovative Korean startups and early-stage companies with high growth potential across ICT, life sciences, deeptech, content, and Brand & Commerce. Premier Partners has established 12 VFs cumulatively.
  • Bio/Healthcare Fund
  • Growth Capital Investment Service Provides growth-stage capital and post-investment value-added support for portfolio companies, leveraging partner expertise across sales, procurement, finance, production, and R&D functions to enhance overall business performance.

Quantifiable outcome

  • KRW 3.53 trillion cumulative AUM since 2005
  • +4 more outcomes

Companies that use Premier Partners

Customer profile

Segments3 records

Ideal customer profiles2 records

Premier Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Premier Partners partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Premier Partners competitors and assessment

Company assessment

Direct peers

  • H&Q Korea: H&Q Korea is a Korean mid-market PE/VC firm of similar scale to Premier Partners; both won 2026 mutual aid association consignment management mandates and compete head-to-head for Korean SME and mid-cap investments.
  • JKL Partners: JKL Partners is a mid-sized Korean PE firm that, alongside Premier Partners and H&Q Korea, captured the bulk of 2026 mutual aid and KIC consignment management mandates after NPS withdrew.
  • Ieum PE (formerly LB Private Equity): Ieum PE is a mid-sized Korean PE firm that won mutual aid/KIC consignment management mandates in 2026 alongside Premier Partners, with a similar focus on Korean SME and mid-cap transactions.
  • Korea Investment Partners: Korea Investment Partners is the PE/VC arm of Korea Investment Holdings, operating multi-stage funds across Korean growth and buyout opportunities and overlapping Premier Partners' SME/mid-cap investment focus.
  • Mirae Asset Venture Investment: Mirae Asset Venture Investment is a Korean VC/PE firm within the Mirae Asset group that invests across early- and growth-stage Korean companies, overlapping Premier Partners' VC and growth-stage mandates.

Broad incumbents

  • IMM Private Equity: IMM Private Equity is one of the largest Korean PE firms, named alongside Premier Partners as a competing Korean PE manager for mutual aid and KIC mandates. Premier Partners' portfolio includes Goodai Global, which IMM led at a KRW 4 trillion valuation.
  • MBK Partners: MBK Partners is the largest Korean PE firm and a recurring competitor for institutional mandates; Premier Partners is identified alongside MBK in the same mutual aid/KIC mandate ecosystem and competes for capital from the same domestic LP base.
  • Hahn & Company: Hahn & Company is a major Korean buyout firm competing with Premier Partners for institutional Korean mandates; both firms pursue mid-to-large cap Korean enterprise investments backed by mutual aid, pension, and financial institution LPs.
  • KDB Capital: KDB Capital is a state-affiliated Korean investment firm operating venture, growth, and infrastructure funds, competing with Premier Partners for domestic institutional capital and SME/mid-cap deal flow.

Regional players

  • Series Investment (한국성장금융): Korea Growth Finance (Series Investment) is a policy-oriented Korean investment firm that invests in SMEs and venture-stage companies, operating as a comparable Korean domestic capital provider alongside Premier Partners' growth-stage and VC activities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Premier Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Premier Partners leadership team

Management profile

Number of profiles

Profiles4 records

Premier Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Premier Partners M&A and investment

M&A and investment

M&A

Investments229 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Premier Partners

What does Premier Partners do?

Premier Partners is a Korean private equity and venture capital fund management firm operating 12 Venture Funds (VFs) and 7 Private Equity Funds (PEFs) with cumulative AUM of approximately KRW 3.53 trillion. The firm provides growth-stage equity capital, board-level governance, and post-investment value-added support to innovative Korean SMEs and mid-cap companies across three specialized divisions: Private Equity, Venture Capital, and Bio/Healthcare.

Is Premier Partners a public or private company?

Premier Partners is a private company. It is classified as management employee owned and is currently operating.

When was Premier Partners founded?

Premier Partners was founded in 2005. It employs 11 to 50 people.

Where is Premier Partners based?

Premier Partners is headquartered in Seoul, South Korea, in the Asia region.

How does Premier Partners make money?

Two revenue lines are on record. Fund Management Fees & Carried Interest is the primary driver. The others are realized Investment Gains (Carry).

Who are Premier Partners's main competitors?

Direct peers on record are H&Q Korea, JKL Partners, Ieum PE (formerly LB Private Equity), Korea Investment Partners and Mirae Asset Venture Investment. Broad incumbents are IMM Private Equity, MBK Partners, Hahn & Company and KDB Capital. Series Investment (한국성장금융) is listed as a regional player.

Does Premier Partners have an API?

No public API is recorded for Premier Partners.

What industry is Premier Partners in?

Premier Partners's product category is Private Equity & Venture Capital Fund Management. Its primary akta.pro industry code is FSANABAA, Large-Cap / Mega-Fund Buyout, with a secondary code of FSAAALAG, Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure). Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ChosunbizHits raises ₩18.3b to launch AI co-scientist in November, targets 2027 lab linkHITS raised 18.3 billion won in a Series B round, with Premier Partners, Korea Investment Partners, and Yuanta Investment participating. The company will launch its AI co-scientist in November and plans to integrate it with automated lab equipment by 2027. The AI system scored 94% on BixBench-Verified-50 and is in beta with 300 researchers.Naver[인터뷰]K-뷰티 M&A 딜엔 반드시 그가 있다 "써보고 판단해요"EY partner Lee Bo-ram advises on K-beauty M&A deals, including the public takeover of VIG Partners' Bioll and Premier Partners' Baem. She stresses sustainability, noting Baem's revenue rose to 126.1 billion won in 2024. She expects K-beauty deals to continue as trends shift.Venturesquare1.55 trillion won invested in humanoids... Holiday Robotics secures the largest Series A investment in the country.Holiday Robotics raised 155 billion won in a Series A, the largest for a Korean startup and humanoid robot firm. The company plans to commercialize its FRIDAY robot this year, aiming for 100 units annually by 2026 and 1,000 by 2027. It will invest in R&D and production infrastructure.스타트업엔(StartupN)Eventric secures 34.5 billion won in pre-IPO investment... preparing for KOSDAQ listing in earnestEventric completed a pre-IPO investment round of 34.5 billion won, with new and existing institutional investors participating. The funds will support R&D, manufacturing expansion, and global growth, and the company has selected Kiwoom Securities as lead underwriter for its KOSDAQ listing. It also secured regulatory approvals for two cerebral infarction devices.MkMedical device maker VAIM to be up for grabsSouth Korean medical device manufacturer VAIM Co., known for its Juvelook wrinkle-reducing filler, is exploring a potential sale with its largest shareholder Premier Partners selecting a financial advisor for the process. The desired sale price is reported at approximately 2 trillion won ($1.39 billion) based on a full equity stake, with potential buyers including private equity funds, foreign cosmetics companies, and large Korean corporations. The company has demonstrated strong financial growth, with revenue increasing nearly sixfold from 10.6 billion won in 2022 to 66.4 billion won in 2024, and an operating margin of 79 percent.VenturesquareAccelerating the development of musculoskeletal regeneration therapy... Akisystem secures 4 billion won in Series A funding.Archisostem BioStrategies secured a 40 billion won Series A investment from Premier Partners, a biotech venture capital firm. The funds will accelerate clinical trials for rotator cuff and osteoarthritis treatments and establish a new R&D center. The company aims to grow into a global cell therapy platform.Venture Capital Access OnlineXCENA Raises $135M Series B to Accelerate Deployment of Memory-Centric Computing SolutionsXCENA closed a $135 million Series B round co-led by Atinum and IMM, bringing total funding to $185 million at a $570 million valuation. The funds will scale customer deployments and advance its MX1 computational memory solution. The company is pursuing additional international fundraising.VenturesquareUpstage raises 180 billion won in Series C round 1 investment... the first unicorn in domestic generative AI.Upstage completed its first Series C round of 180 billion won, valuing the company at over 1 trillion won and making it the first domestic generative AI unicorn. The round was led by Saje Partners, with cumulative investment reaching about 400 billion won. The company plans to expand GPU infrastructure, hire global talent, and enter overseas markets.Defense WorldPremier Path Wealth Partners LLC Sells 4,859 Shares of Vanguard Total Stock Market ETF $VTIPremier Path Wealth Partners LLC reduced its position in Vanguard Total Stock Market ETF (VTI) by 81.6% in Q4, selling 4,859 shares, with holdings valued at $367,000 at period end. The article also notes several other institutional investors adjusted their positions, including Vanguard Group Inc. (now holding 60.3 million shares worth $19.8 billion), Rakuten Investment Management Inc., Wealthfront Advisers LLC, WealthNavi Inc., and HB Wealth Management LLC. VTI has a market capitalization of $585.40 billion and trades at $335.05 per share.MobiHealthNewsKorean company behind retina-based CVD risk AI plans to go publicMediwhale, a South Korean medical AI startup, has raised $13 million in Series C funding led by private equity firm Premier Partners, bringing its total raised capital to $34 million. The company develops AI-powered software that analyzes retinal images to predict cardiovascular and chronic kidney disease risk, with its flagship product Dr Noon CVD deployed in over 170 hospitals globally. The funding will support US market entry, FDA De Novo regulatory approval, clinical trials, and preparations for a technology special listing on the KOSDAQ stock exchange in the first half of 2027.